Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 463,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 18%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People's Republic of China. The company offers cell-based immunotherapies, including CAR-T treatment, a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) immunotherapy for...

Industry: Biotechnology
Sector: Healthcare
Phone: 86 40 0820 0033
Address:
Building B, 5th Floor No. 699 Zhong Ke Road Pudong New District, Shanghai, China
Latest News on JWCTF
No data available.